Effect of cis-unsaturated fatty acids, prostaglandins, and free radicals on angiotensin-converting enzyme activity in vitro

Proceedings of the Society for Experimental Biology and Medicine

Volumn 214, Issue 4, 1997, Pages 374-379

  Vijay Kumar, K ^a   Das, U N ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FREE RADICAL; HYDROGEN PEROXIDE; HYDROXYL RADICAL; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PROSTAGLANDIN DERIVATIVE; SUPEROXIDE; UNSATURATED FATTY ACID;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; VASODILATATION;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ARACHIDONIC ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; FREE RADICALS; HUMANS; HYDROGEN PEROXIDE; HYPERTENSION; MALE; MIDDLE AGED; NEUTROPHILS; NITRIC OXIDE; NITROPRUSSIDE; PEPTIDYL-DIPEPTIDASE A; PROSTAGLANDINS;

EID: 0030919056     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Caldwell PRB, Seagal BC, Heu KC, Das M. Angiotensin Converting enzyme: Vascular endothelial localization. Science 191:1050-1051, 1976.
2. Ozau VJ, Pratt RE. Renin-angiotensin system: Biology, physiology and pharmacology. In: Haser E, Morgan H, Ketz A, Fozzard H, Eds. Handbook of Experimental Cardiology. New York: Raven Press, pp1631-1661, 1986.
3. Dezso B, Jacobson J, Poulsen K. Evidence for the presence of angiotensins in normal, unstimulated alveolar macrophages and monocytes. J Hypertension 7:5-11, 1989.
4. Ozau VJ, Gibbons GH. Autocrine-paracrine mechanism of vascular myocytes in hypertension. Am J Cardiol 60:991-1031, 1987.
5. Ikemoto F, Song G, Tominga M, Yamamoto K. Oxidation-induced increase in activity of ACE in the rat kidney. Biochem Biophys Res Commun 153:1032-1037, 1988.
6. Armstrong B, Van Merwyk AJ, Coates H. Blood pressure in seventh day adventist vegetarians. Am J Epidemiol 105:444-449, 1977.
7. Sacks FM, Rosner B, Lass EH. Blood pressure in vegetarians. Am J Epidemiol 100:390-398, 1974.
8. Mill DE, Ward RP. Attenuation of psychosocial stress-induced hypertension by GLA administration. Proc Soc Exp Biol Med 176:32-37, 1984.
9. Hassal CH, Kirtland SJ. Dihomogamma-linolenic acid reverses hypertension induced in rats by diets rich in saturated fat. Lipids 19:699-603, 1984.
10. Singer P, Jaeger W, Voigt S. Defective desaturation and elongation of n-6 and n-3 fatty acids in hypertensive patients. Prostaglandins Leukot Med 15:159-165, 1984.
11. Singer P, Voigt S, Moritz V. Changes in polyunsaturated fatty acids in serum lipids of spontaneously hypertensive rats during the onset of high BP. Prostaglandins Leukotr Med 12:399-408, 1983.
12. Suryaprabha P, Das UN, Koratkar R, Sangeetha P, Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled hypertension. Prostaglandins Leukotr Essent Fatty Acids 41:27-33, 1990.
13. Vijay Kumar K, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 19:59-66, 1993.
14. Das UN, Sandhya P. Modification of leukocyte alkaline phosphatase activity in chronic myelod leukemia by colchine and imidazole: Relevance to alteration in thromboxane A2 and prostaglandins. ICRS Med Sci 10:226, 1982.
15. Sandhya P, Das UN. Modification of normal human leukocyte alkaline phosphatase activity by prostaglandin E1 and prostaglandins F2 alph. IRCS Med Sci 11:218, 1983.
16. Ronca-Testone S. Direct spectrophotometric assay for angiotensin converting enzyme in serum. Clin Chem 29:1093-1096, 1983.
17. Lowry OH, Rosebrough NJ, Fan AL, Randal RJ. Protein measurement with folin phenol reagent. J Biol Chem 193:265-275, 1955.
18. Rees DD, Palmer RMJ, Moncada S. Role of endothelium derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A 86:3375-3378, 1989.
19. Bolger PM, Eisner GM, Ramwell PW, Slotkoff LM, Corey EJ. Renal actions of prostacyclin. Nature 271:467-469, 1978.
20. Vanhoutte PM. The end of the quest? Nature 327:459-460, 1987.
21. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 327:524-526, 1987.
22. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium derived vascular relaxing factor. Nature 320:454-456, 1986.
23. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium derived contracting factor. Am J Physiol 257:433-437, 1989.
24. Nalazpmp L, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 88:10045-10048, 1991.
25. Sanders TAB, Vickers M, Haines AP. Effect of blood lipids and haemostasis of a supplement of cod liver oil in EPA and DHA in the healthy human subjects. Clin Sci 61:317-324, 1981.
26. Goodfriend TL, Ball DL. Fatty acid effects on angiotensin receptors. J Cardiovasc Pharmacol 8:1276-1283, 1986.
27. Hui R, Falardeau P. Antihypertensive properties of linolic acid and fish oil omega 3 fatty acids independent of the PG system. Am J Hypertension 2:610-617, 1989.
28. Berry EM, Hirsch J. Does dietary linolenic acid influences BP? Am J Clin Nutr 44:336-340, 1986.
29. Knapp HR, Fitzgerald GA. The anti-hypertensive effects of fish oil. A controlled study of PUFAs supplementation in essential hypertension. N Engl J Med 320:1037-1043, 1989.
30. Shimokawa H, Vanhoutte PM. Dietary cod liver oil improves endothelium dependent relaxation in hypercholesterolemic atherosclerotic porcine coronary arteries. Circulation 78:1421-1430, 1988.
31. Okunishi H, Kawamoto T, Kuribe Y, Oka Y, Ishi K, Tanaka T, Miyazaki M. Pathogenic role of vascular angiotensin converting enzyme in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 18:649-651, 1991.
32. Shiota N, Miyazaki M, Okunishi H. Increase of angiotensin converting enzyme gene expression in the hypertensive aorta. Hypertension 20:168-174, 1992.
33. Das UN. Essential fatty acids: Biology and their clinical implications. Asian Pac J Pharmacol 6:317-330, 1991.
34. Horrobin DF. Medical roles of metabolites of precursor EFA. INFORM 6:428-435, 1995.
35. Fujioka T, Saito S, Saito E, Mizumura T, Honya J, Kanno H, Matumoto T, Ueno T, Takahashi Y, Watanabe H, Yasugi T. Serum lipids, apolipoproteins and polyunsaturated fatty acids levels in patients with coronary heart disease. In: Yasugi T, Nakamura H, Soma M, Eds. Advances in Polyunsaturated Fatty Acid Research. Amsterdam: Excerpta Medica, International Congress Series 1025, pp149-1521, 1993.
36. Park JW, Means GE. Inactivation of angiotensin converting enzyme by sodium nitroprusside. Biochem Biophys Res Commun 145:1048-1053, 1987.